Dataset Information

An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk Factors

ABSTRACT: Direct infusion high-resolution mass spectrometry (DIHRMS) is a novel, high-throughput approach to rapidly and accurately profile hundreds of lipids in human serum without prior chromatography, facilitating in-depth lipid phenotyping for large epidemiological studies to reveal the detailed associations of individual lipids with coronary heart disease (CHD) risk factors. Intact lipid profiling by DIHRMS was performed on 5662 serum samples from healthy participants in the Pakistan Risk of Myocardial Infarction Study (PROMIS). We developed a novel semi-targeted peak-picking algorithm to detect mass-to-charge ratios in positive and negative ionization modes. We analyzed lipid partial correlations, assessed the association of lipid principal components with established CHD risk factors and genetic variants, and examined differences between lipids for a common genetic polymorphism. The DIHRMS method provided information on 360 lipids (including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, and sterol lipids), with a median coefficient of variation of 11.6% (range: 5.4-51.9). The lipids were highly correlated and exhibited a range of associations with clinical chemistry biomarkers and lifestyle factors. This platform can provide many novel insights into the effects of physiology and lifestyle on lipid metabolism, genetic determinants of lipids, and the relationship between individual lipids and CHD risk factors.

INSTRUMENT(S): Direct infusion MS - positive

PROVIDER: MTBLS4461 | MetaboLights | 2024-02-02

REPOSITORIES: MetaboLights

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	20130802__AK__1__010__M227.raw	Raw
	20130802__AK__1__011__FC1034.raw	Raw
	20130802__AK__1__012__X1622.raw	Raw
	20130802__AK__1__013__LY3218.raw	Raw
	20130802__AK__1__014__RC1774.raw	Raw

Items per page:

1 - 5 of 7347

Publications

An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk Factors.

Harshfield Eric L EL Koulman Albert A Ziemek Daniel D Marney Luke L Fauman Eric B EB Paul Dirk S DS Stacey David D Rasheed Asif A Lee Jung-Jin JJ Shah Nabi N Jabeen Sehrish S Imran Atif A Abbas Shahid S Hina Zoubia Z Qamar Nadeem N Mallick Nadeem Hayyat NH Yaqoob Zia Z Saghir Tahir T Rizvi Syed Nadeem Hasan SNH Memon Anis A Rasheed Syed Zahed SZ Memon Fazal-Ur-Rehman FU Qureshi Irshad Hussain IH Ishaq Muhammad M Frossard Philippe P Danesh John J Saleheen Danish D Butterworth Adam S AS Wood Angela M AM Griffin Julian L JL

Journal of proteome research 20190426 6

Direct infusion high-resolution mass spectrometry (DIHRMS) is a novel, high-throughput approach to rapidly and accurately profile hundreds of lipids in human serum without prior chromatography, facilitating in-depth lipid phenotyping for large epidemiological studies to reveal the detailed associations of individual lipids with coronary heart disease (CHD) risk factors. Intact lipid profiling by DIHRMS was performed on 5662 serum samples from healthy participants in the Pakistan Risk of Myocardi ...[more]

PMID: 30887811

Similar Datasets

Project description:Hispanics of Mexican American descent in South Texas show a very high prevalence of MASLD, with some studies reporting rates as high as 50% in adults. However, assessment of genetic risk factors underlying this prevalence is complicated by a high co-occurrence of other metabolic disorders and variable endogenous and exogenous environmental risk factors. To map the genetic architecture of MASLD hepatic steatosis risk, we conducted an epidemiological-scale investigation using human induced pluripotent stem cell (iPSC)-derived hepatocyte cultures from 193 participants in our longitudinal South Texas Family Study (STFS). iPSC-based models offer greater power to map genetic risk factors by experimentally controlling for confounding organismal and environmental factors. We combined transcriptome-wide gene expression analysis with high-content cellular measurements of neutral lipids to define a core hepatic steatosis MASLD phenotype at baseline (vehicle-treated) and following a lipid challenge. The additive genetic heritability of hepatic steatosis measures was 0.44 (p-value = 0.03) at baseline and 0.42 (p-value = 0.03) at post-lipid-challenge. Multivariable linear regression comparing each gene’s expression against hepatic steatosis measures identified 1,070 genes at baseline and 1,229 genes post-lipid challenge, whose expression showed a transcriptome-wide statistically significant association (standardized |β| ≥ 0.24; Bonferroni-corrected p-value ≤ 0.001) with baseline and post-lipid challenge hepatic steatosis measures, respectively. Functional annotation and pathway enrichment analyses of these genes implicated a broad range of hepatocellular functions, mapping an overall genetic architecture of MASLD-associated steatosis risk in Mexican Americans. The genes whose expression was positively correlated with hepatic steatosis measures suggest a direct role of variation in fatty acid (FA) and cholesterol uptake, de novo lipogenesis (DNL), and carbohydrate shunts in hepatic steatosis risk, as well as a cellular stress-associated and high-turnover metabolic state marked by elevated FA-oxidation and ketogenesis. In contrast, the genes whose expression was inversely correlated with hepatic steatosis measures suggest a significant role of the cellular cytoskeleton, hepatocyte epithelial integrity, and endosomal and autophagic clearance machinery in steatosis risk.

Project description:How humans differ from one another at the molecular level and the impact of ethnicity, age and environmental factors such as diet and geography are poorly understood. To address this gap, we analyzed 322 nominally healthy individuals from diverse ethnic backgrounds located in distinct geographical regions, using (1) deep multi-omic profiling - including genome sequencing, transcriptomics, glycomics, targeted and untargeted metabolomics, lipidomics, proteomics, 16S microbiota sequencing, metaproteomics, metallomics, and metabolic hormone and pathogen profiling, (2) clinical data collection, and (3) comprehensive lifestyle surveys. Our integrative analysis revealed several key findings: associations between molecular profiles (transcripts, proteins, metabolites, lipids, glycans, and microbiota) and age, ethnicity, and geographical residence (including diet) among healthy individuals; ethnicity-specific genetic polymorphisms in key genes governing whole-body homeostasis, particularly in lipid/carbohydrate metabolism and neuroinflammation pathways; and variation in the abundance of key proteins such as the TERF2 interacting protein (TERF2IP) which is critical for cellular aging, genome stability, and protection against chromosomal degradation. These findings hold significant translational value, particularly in understanding ethnicity as a risk factor for autoimmune diseases. Many ethnicity-associated molecules identified in our study interact with existing therapeutic drugs, highlighting the potential need for ethnicity-specific drug dosing adjustments. Furthermore, our results suggest that geographical factors influence ethnic patterns, which may, in turn, affect longevity. individuals with European ancestry exhibited a lower phenotypic age, while those of Asian ancestry showed a higher phenotypic age when living outside their ancestral regions. By providing both a comprehensive baseline dataset of multi-omic variation in healthy individuals and critical insights into the molecular basis of human diversity, our study enhances our understanding of how environmental and genetic factors influence phenotypic and molecular traits and potentially augments individualized health approaches.

Project description:Background---For decades, plasma lipid levels have been known risk factors of atherosclerosis. Recently, inflammation has gained acceptance as a crucial event in the pathogenesis and development of atherosclerosis. A number of studies have provided some insights into the relationships between the two aspects of atherosclerosis: plasma lipids --- the risk factors, and circulating leukocytes --- the effectors of inflammation. In this study, we investigate the relationships between plasma lipids and leukocytes. Methods and Results---No significant correlation was found between leukocyte counts and plasma lipid levels in 74 individuals. Profiling and analyzing the leukocyte gene expression of 32 individuals revealed distinctive patterns in response to plasma lipid levels: 1) genes involved in lipid metabolism and in the electron transport chain were positively correlated with triglycerides and low-density lipoprotein cholesterol levels, and negatively correlated with high-density lipoprotein cholesterol levels; 2) genes involved in platelet activation were negatively correlated with high-density lipoprotein cholesterol levels; 3) transcription factors regulating lipidgenesis-related genes were correlated with plasma lipid levels; 4) a number of genes correlated to plasma lipid levels were found located in the regions of known QTLs associated with hyperlipemia. Conclusions--- We discovered interesting patterns of leukocyte gene expression in response to plasma lipid levels. Most importantly, genes involved in lipid metabolism, the electron transportation chain, and platelet activation were found correlated with plasma lipid levels. We suggest that leukocytes respond to changing plasma lipid levels by regulating a network of genes, including genes involved in lipid and fatty acid metabolism, through the activation of key transcription factors, such as sterol regulatory element binding transcription factors and peroxisome proliferative activated receptors. Experiment Overall Design: 1. Profile gene expression in human peripheral blood cells. Experiment Overall Design: 2. Test blood biochemistry and blood cell differential counts Experiment Overall Design: 3. Examine the correlation between blood gene expression and blood lipid levels. Experiment Overall Design: 4. Explore possible pathways with significant genes. Experiment Overall Design: 5. Validate a number of significant genes with RT-PCR

Project description:A long-standing aspiration in multi-omics is to comprehensively understand how genetic and geographical factors shape phenotypic expression at the molecular, cellular and organismal level - ultimately revealing how the interplay between an organism's molecular landscape and its environment manifests in observable traits. While high-throughput multi-omics technologies have revolutionized our understanding of disease states, relatively few studies have explored molecular variation within and across healthy populations, especially with full-spectrum molecular data, leaving a significant knowledge gap. To address this gap and enhance our understanding of human molecular diversity, we conducted an analysis of 322 nominally healthy individuals from diverse ethnic backgrounds, integrating (1) deep multi-omic profiling - including genome sequencing, transcriptomics, glycomics, targeted and untargeted metabolomics, lipidomics, proteomics, 16S microbiota sequencing, metaproteomics, metallomics, and metabolic hormone and pathogen profiling, (2) clinical data collection, and (3) comprehensive lifestyle surveys. Our integrative analysis revealed three key findings: associations between molecular profiles (transcripts, proteins, metabolites, lipids, and microbiota) and phenotypic categories such as diet and age among healthy individuals; ethnicity-specific genetic polymorphisms in key genes governing whole-body homeostasis, particularly in lipid/carbohydrate metabolism and neuroinflammation pathways; and variation in the abundance of key proteins such as the TERF2 interacting protein (TERF2IP) which is critical for cellular aging, genome stability, and protection against chromosomal degradation. These findings hold significant translational value, particularly in understanding ethnicity as a risk factor for autoimmune diseases. Many ethnicity-associated molecules identified in our study interact with existing therapeutic drugs, highlighting the potential need for ethnicity-specific drug dosing adjustments. Furthermore, our results suggest that geographical factors influence ethnic patterns, which may, in turn, affect longevity. Male individuals with European ancestry exhibited a lower phenotypic age, while those of Asian ancestry showed a higher phenotypic age when living outside their ancestral regions. By providing both a comprehensive baseline dataset of multi-omic variation in healthy individuals and critical insights into the molecular basis of human diversity, our study establishes a foundation for future precision medicine approaches and enhances our understanding of how environmental and genetic factors influence phenotypic and molecular traits.